{"transactions":[{"id":2219779,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":125785,"kind":"person","name":"DAmour Kevin","position":1,"cik":"0001870486","reported_name":"DAmour Kevin","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2022-06-30T00:01:50.000Z","date":"2022-06-28","kind":"exercise","acquired":false,"shares":17573,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit converts into one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 28, 2021, the reporting person was granted 70,290 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 28, 2021, the reporting person was granted 70,290 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date."}],"balance_after":52717,"derivative":{"underlying":"Common Stock","underlying_shares":17573},"source":{"system":"sec-edgar","filing":"0001140361-22-024524","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122024524/form4.xml","form_type":"4"}},{"id":2219778,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":125785,"kind":"person","name":"DAmour Kevin","position":1,"cik":"0001870486","reported_name":"DAmour Kevin","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-06-30T00:01:50.000Z","date":"2022-06-28","kind":"tax_withholding","acquired":false,"shares":6077,"price":0.5534,"value":3363.0118,"ownership":{"direct":true},"balance_after":11496,"source":{"system":"sec-edgar","filing":"0001140361-22-024524","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122024524/form4.xml","form_type":"4"}},{"id":2219777,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":125785,"kind":"person","name":"DAmour Kevin","position":1,"cik":"0001870486","reported_name":"DAmour Kevin","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-06-30T00:01:50.000Z","date":"2022-06-28","kind":"exercise","acquired":true,"shares":17573,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit converts into one share of common stock."}],"balance_after":17573,"source":{"system":"sec-edgar","filing":"0001140361-22-024524","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122024524/form4.xml","form_type":"4"}},{"id":2329638,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":125785,"kind":"person","name":"DAmour Kevin","position":1,"cik":"0001870486","reported_name":"DAmour Kevin","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2022-03-18T01:00:37.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":138400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable in 36 substantially equal monthly installments from the grant date."}],"balance_after":138400,"derivative":{"exercise_price":1.93,"expiration_date":"2032-03-11","underlying":"Common Stock","underlying_shares":138400},"source":{"system":"sec-edgar","filing":"0001140361-22-009984","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122009984/form4.xml","form_type":"4/A","original_submission_date":"2022-03-15"}},{"id":2334479,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":125785,"kind":"person","name":"DAmour Kevin","position":1,"cik":"0001870486","reported_name":"DAmour Kevin","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2022-03-16T01:34:31.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":138400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable over three years, with 25% of the options vesting on the one-year anniversary of the grant date and the remaining options vesting in 24 substantially equal monthly installments thereafter."}],"balance_after":138400,"derivative":{"exercise_price":1.93,"expiration_date":"2032-03-11","underlying":"Common Stock","underlying_shares":138400},"source":{"system":"sec-edgar","filing":"0001140361-22-009664","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122009664/form4.xml","form_type":"4"}},{"id":2650978,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":125785,"kind":"person","name":"DAmour Kevin","position":1,"cik":"0001870486","reported_name":"DAmour Kevin","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Unit","published_at":"2021-07-01T01:34:49.000Z","date":"2021-06-28","kind":"grant","acquired":true,"shares":70290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Unit vests and becomes exercisable in four equal installments on June 28 of each of 2022, 2023, 2024 and 2025, provided they shall vest in full immediately prior to a Change in Control (as defined in Dr. D'Amour's Executive Employment Agreement, dated as of June 5, 2021 and effective as of June 28, 2021), subject to continued service through each vesting date."}],"balance_after":70290,"derivative":{"expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":70290},"source":{"system":"sec-edgar","filing":"0001140361-21-023007","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036121023007/form4.xml","form_type":"4"}},{"id":2650977,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":125785,"kind":"person","name":"DAmour Kevin","position":1,"cik":"0001870486","reported_name":"DAmour Kevin","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option","published_at":"2021-07-01T01:34:49.000Z","date":"2021-06-28","kind":"grant","acquired":true,"shares":140580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over four years, with twenty-five percent of the shares covered thereby vesting on June 28, 2022, and 1/36 of the remaining shares covered thereby vesting on the 28th day of each calendar month from July 28, 2022 through June 28, 2025, subject to continued service through each vesting date."}],"balance_after":140580,"derivative":{"exercise_price":21.35,"expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":140580},"source":{"system":"sec-edgar","filing":"0001140361-21-023007","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036121023007/form4.xml","form_type":"4"}}]}